Laurence Baker is an expert in the areas of health economics, healthcare policy, and life sciences. Professor Baker studies the organization and economic performance of U.S. healthcare and pharmaceutical markets, with a focus on issues related to financial incentives, competition, pricing and provider payment, labor, and technology adoption. In the health insurance arena, he has expertise in private insurance, managed care, Medicare Part D, Medicare Advantage, and Medicaid.
Professor Baker has been retained as an expert witness in numerous healthcare and life sciences matters. He has testified in depositions and trials, on issues involving:
- Healthcare insurance competition
- Antitrust and intellectual property issues in life sciences matters, including alleged generic entry delay through reverse payments and other allegedly collusive agreements between drug manufacturers
- Alleged inappropriate use, or inappropriate pricing, of medical services and prescription drugs
- Mergers between hospitals and physician groups
- Alleged exclusionary contracting practices by health insurers and health providers
- Alleged collusive and no-poach labor agreements between health providers
- Regulatory issues in healthcare
Professor Baker has extensive experience addressing issues of class certification (of both direct and indirect purchasers) as well as evaluating liability and damages.
In his research, Professor Baker has examined the relationship between physician practice characteristics and competition and healthcare delivery, prices, and outcomes. He has also studied the effects of managed care insurance practices on the healthcare system; the impact of regulation on healthcare markets; the determinants and results of technological change in medicine; and patient safety in U.S. hospitals. In addition, Professor Baker has addressed topics related to physicians’ incomes and career choices and analyzed how the internet and email influence healthcare delivery and outcomes.
Professor Baker was awarded the ASHEcon Medal for his significant contributions to the field of health economics and has been elected to the National Academy of Medicine. He has twice been honored for excellence in teaching. His publications include articles in JAMA—The Journal of the American Medical Association, the New England Journal of Medicine, the RAND Journal of Economics, Health Services Research, and Health Affairs.
Value Drug Company v. Takeda Pharmaceuticals U.S.A. Inc. et al.
In re Novartis and Par Antitrust Litigation
Cornerstone Research Nominated for Global Competition Review Awards 2020
Hospital Pricing Challenged in Class Action
Oscar Insurance Company of Florida v. Blue Cross and Blue Shield of Florida, Inc. et al.
Class Action Related to Changes in Retirees’ Health Insurance Plans
Cornerstone Research and SIEPR Cosponsored Healthcare Conference
Class Certification Opposed on Behalf of Healthcare Provider
- Value Drug Company v. Takeda Pharmaceuticals U.S.A. Inc. et al.
- In re Novartis and Par Antitrust Litigation
- Hospital Pricing Challenged in Class Action
- Oscar Insurance Company of Florida v. Blue Cross and Blue Shield of Florida, Inc. et al.
- Class Action Related to Changes in Retirees’ Health Insurance Plans
- Class Certification Opposed on Behalf of Healthcare Provider